Palladia or Palladia plus Radiation Therapy in Cats with Oral Squamous Cell Carcinoma

Study Details:

Species: cats

Tumor type: Oral Squamous Cell Carcinoma

Purpose of Study: The purpose of this study is to identify the activity of toceranib phosphate (Palladia) alone or as a radiation sensitizing agent in the treatment of feline oral squamous cell carcinoma. Inclusion Criteria:

  • Have histologically or cytologically confirmed diagnosis of oral SCC
  • Have a life expectancy of at least 6 weeks
  • Have no evidence of metastatic disease at the time of enrollment
  • Have no other serious health problems that are incompatible with the study (as renal, cardiac or hepatic insufficiency)

For more information, click here.